Innovations

Found results: 1005

Note to the businessman

"Innovation Initiative": awarding the winners

What developments are of interest to leading multinational corporations? The answer to this question is given by the results of the competition "Innovation Initiative", the results of which were summed up in Moscow.

12.03.2010
Biotechnologies - into life

Personalized medicine today and tomorrow

Many are already dreaming of the time when personalized medicine will fully come into its own and genome sequencing will become a routine medical test, which will allow each person to optimize the quality and duration of their life immediately after birth.

04.03.2010
Biotechnologies - into life

RUSNANO joined the fight against old age

The total budget of the project for the production of anti–aging drugs based on Skulachev ions will be up to 1.8 billion rubles, of which RUSNANO's share will be up to 710 million.

24.02.2010
Note to the businessman

Development of new drugs adjusted for the crisis

Investments in R&D of new medicines increased throughout 2009, despite the crisis, but the distribution of funds between various areas of innovative drug development has changed markedly.

17.02.2010
Biotechnologies - into life

Russian-Indian biotechnological intentions

Russia and India are planning joint projects on biotechnology: a scientific and educational center in the field of biotechnology and pharmaceuticals, a business incubator on agrobiotechnology, vaccine production, a project on the use of stem cells in ophthalmology, etc.

15.02.2010
Note to the businessman

Pharmaceutical industrial zone near St. Petersburg

Despite the mood of the St. Petersburg authorities to make it a priority to attract Russian manufacturers, the pharmaceutical cluster, obviously, will not be limited to domestic companies: there are still few Russian pharmaceutical companies ready to make serious investments.

10.02.2010
Biotechnologies - into life

Plant cells synthesize biological products

The use of an innovative platform for the biosynthesis of drugs in plant cell culture is an important step towards reducing the cost and increasing the efficiency of the production of biopharmaceutical drugs.

09.02.2010
Note to the businessman

Russian venture in full ambition

The strategy of the "Russian Venture Company" is ambitious. The key indicator is an increase in the volume of the venture market by 2020 to 60-300 billion rubles from the current 1.5–2 billion rubles.

28.01.2010
Note to the businessman

Small business in the Russian pharmaceutical industry

How do representatives of science, innovative business and those who are called upon to create conditions for the rise of this important industry understand the ways of pharmaceutical development in Russia?

26.01.2010
Note to the businessman

Pharmaceutical market-2010

In 2010, pharmaceutical companies will shift the point of application of forces to the markets of developing countries. The legacy of the past remains the economic crisis, a small innovative activity of pharmaceutical manufacturers, the problem of generics and savings in healthcare costs.

20.01.2010
Biotechnologies - into life

Biotechnology: the main ways of development

The rapid development of modern biotechnologies is taking place in several key areas at once, in each of which promising results have already been achieved.

14.01.2010
Note to the businessman

Big Pharme – big swimming

This publication presents the key trends that will determine the development of Big Pharma in the new year 2010.

29.12.2009
Biotechnologies - into life

Biotechnology in Russia: White Silence

Industrial, or as it is also called "white", biotechnology is considered one of the most promising innovative industries. In Russia, this industry is practically frozen.

28.12.2009
Note to the businessman

The past year has been a turning point for the biotechnology industry

2012 should have an even stronger impact on the global biotechnology industry, when patent protection of hundreds of drugs will end. This fact is able to reverse the negative trend of the beginning of this year, when tens of thousands of biotechnologists were left on the street: big pharma will need new effective molecules.

23.12.2009
Biotechnologies - into life

Innovations in life science: the "hot ten" of 2009

The Scientist magazine convened a jury of competent experts whose task was to select the ten best innovations that appeared on the market of devices and methods for conducting research in the field of life science in 2009.

16.12.2009